Rocket Pharmaceuticals
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -2,146 | |||
EBITDA | 136,557 | -44,975 | -37,012 | -46,619 |
EBIT | 132,308 | -47,121 | -39,229 | -49,859 |
Net Income | 123,214 | -47,594 | -42,538 | -50,332 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -39,621 | -45,487 | -34,920 | -50,374 |
Cash | 224,507 | 49,610 | 77,558 | 75,948 |
Basic Shares | 114,513 | 112,134 | 111,123 | 111,571 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -11,025 | -9,375 | -7,098 | -6,266 |
EBITDA | -210,207 | -247,485 | -236,622 | -213,688 |
EBIT | -221,232 | -256,860 | -243,720 | -219,954 |
Net Income | -223,123 | -258,746 | -245,595 | -221,863 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -190,454 | -215,586 | -211,388 | -186,761 |
Cash | 77,558 | 163,635 | 55,904 | 140,517 |
Basic Shares | 111,123 | 94,807 | 84,009 | 68,148 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.15 |
2026-03-31 | -$0.42 |
2025-12-31 | -$0.38 |
2025-09-30 | -$0.45 |